Rowland Carmichael Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $302K | Sell |
8,205
-2,551
| -24% | -$93.9K | 0.1% | 228 |
|
|
2020
Q3 | $375K | Buy |
10,756
+82
| +0.8% | +$2.86K | 0.15% | 166 |
|
|
2020
Q2 | $331K | Buy |
10,674
+44
| +0.4% | +$1.36K | 0.14% | 178 |
|
|
2020
Q1 | $329K | Buy |
10,630
+2,077
| +24% | +$64.3K | 0.17% | 155 |
|
|
2019
Q4 | $318K | Hold |
8,553
| – | – | 0.11% | 214 |
|
|
2019
Q3 | $292K | Buy |
8,553
+587
| +7% | +$20K | 0.1% | 221 |
|
|
2019
Q2 | $327K | Hold |
7,966
| – | – | 0.11% | 191 |
|
|
2019
Q1 | $321K | Hold |
7,966
| – | – | 0.12% | 185 |
|
|
2018
Q4 | $330K | Hold |
7,966
| – | – | 0.15% | 165 |
|
|
2018
Q3 | $333K | Hold |
7,966
| – | – | 0.13% | 184 |
|
|
2018
Q2 | $274K | Hold |
7,966
| – | – | 0.12% | 208 |
|
|
2018
Q1 | $268K | Hold |
7,966
| – | – | 0.15% | 193 |
|
|
2017
Q4 | $274K | Sell |
7,966
-721
| -8% | -$24.8K | 0.14% | 195 |
|
|
2017
Q3 | $294K | Buy |
8,687
+721
| +9% | +$24.4K | 0.16% | 170 |
|
|
2017
Q2 | $254K | Sell |
7,966
-304
| -4% | -$9.69K | 0.15% | 184 |
|
|
2017
Q1 | $268K | Buy |
8,270
+86
| +1% | +$2.79K | 0.16% | 168 |
|
|
2016
Q4 | $252K | Sell |
8,184
-656
| -7% | -$20.2K | 0.15% | 188 |
|
|
2016
Q3 | $284K | Sell |
8,840
-11
| -0.1% | -$353 | 0.18% | 166 |
|
|
2016
Q2 | $296K | Buy |
8,851
+1,439
| +19% | +$48.1K | 0.19% | 157 |
|
|
2016
Q1 | $208K | Buy |
+7,412
| New | +$208K | 0.19% | 129 |
|